Clinical trial · Interventional
Microtransplantation for Ovarian Cancer
NCT05095558CI-TRIAL-00054711unknownPhase 1 / Phase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study, we will apply micro transplantation to the field of recurrent and advanced ovarian cancer to study the efficacy and safety.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer Recurrent | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| microtransplantation, HLA-mismatched donor peripheral stem cell infusion | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- MST
- description
- standard chemotherapy with microtransplantation
- interventionNames
- Biological: microtransplantation, HLA-mismatched donor peripheral stem cell infusion
- type
- NO_INTERVENTION
- label
- CT
- description
- standard chemotherapy only, without microtransplantation
Primary outcomes (2)
- measure
- Treatment-Emergent Adverse Events
- timeFrame
- 1 month
- description
- Treatment related mortality
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients are 18-80 years old, female，regardless of race; * Advanced / relapsed ovarian cancer confirmed by clinical or histopathological diagnosis; * More than two kinds of tumors are allowed; * Karnofsky score ≥ 60, ECoG physical status ≤ 2; * Sensitive to chemotherapy or radiotherapy; * There are measurable lesions; * There are suitable hematopoietic stem cell donors Exclusion Criteria: * have no suitable donor or donor refused * patient refused to accept donor cells
References
Publications (0)
Data not yet available
No reference posted for this study.